Navigation Links
Carl Marks Seeds New Healthcare Fund Through Strategic Partnership With BlueStar Capital Management
Date:11/28/2007

NEW YORK, Nov. 28 /PRNewswire/ -- Carl Marks & Co. LP has partnered with BlueStar Capital Management LP to launch the BlueStar CM Life Sciences Focus Fund LP. The partnership also gives Carl Marks a stake in BlueStar Capital Management, which invests in healthcare hedge funds, and an increased presence in the healthcare investment sector.

The new Focus Fund invests in highly concentrated portfolios which are long and short public healthcare equities, in both managed accounts and limited partnerships.

"We feel the healthcare market provides attractive and solid investment opportunities," said Mark Claster, president of Carl Marks & Co., "and BlueStar Capital Management's long experience with healthcare hedge funds makes this the perfect strategic relationship for our investment interests."

Carl Marks's Andrew Boas will join BlueStar Capital's Advisory Board. Boas is a principal of Carl Marks Management Company.

Jonathan Lach of BlueStar Capital said, "The Focus Fund is invested in the best ideas of some of the best investors in public healthcare equities, a sector that is rich with investment opportunity. We are very pleased to be partnering with Carl Marks, an extremely fine firm with much to contribute to our mutual success."

About Carl Marks & Co.

Founded in 1925, Carl Marks began as a dealer of foreign securities in the United States. The company has diversified into a multi-faceted investment and advisory services firm offering a range of specialized services, including corporate revitalization and investment banking, distressed securities, private equity, real estate and asset management. For more information, visit http://www.carlmarks.com.

About BlueStar Capital Management LP

BlueStar Capital Management LP invests primarily in healthcare hedge funds and provides investment and consulting services for its clients in this dynamic investment sector. The firm manages BlueStar Life Sciences LP, a healthcare sector of funds, and BlueStar CM Life Sciences Focus Fund LP, which invests in a more concentrated manner in the healthcare sector. Additional information about BlueStar Capital Management is available at http://www.bluestar-capital.com.


'/>"/>
SOURCE Carl Marks & Co. LP
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event
2. Social Network for Scientists Marks Ten Years Online
3. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
4. Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results
5. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
6. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
7. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
8. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
9. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
10. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
11. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2017)... ... 15, 2017 , ... Algenist is continuing to disrupt the ... cream with a patented formula, clinically proven to deliver visible firming results in ... Cream to our already innovative ELEVATE product line,” said vice president of product ...
(Date:5/12/2017)... ANN ARBOR, Mich. , May 12, 2017 /PRNewswire/ ... been selected to present at the 36th annual Michigan ... Investment Forum. GreenMark, a Delaware ... will be presenting to investors in attendance, including more ... to deliver health benefits to society through biobased targeting ...
(Date:5/11/2017)... SEATTLE, WA (PRWEB) , ... May 11, 2017 , ... ... regulatory review, is proud to announce that it has joined SMART IRB , ... The goal of SMART IRB is to ease burdens related to multi-site research and ...
(Date:5/10/2017)... ... May 10, 2017 , ... Shimadzu Scientific Instruments ... a host of technologically advanced features, resulting in a modernized instrument that improves ... yields a higher return on investment. , Engineered with the analyst in ...
Breaking Biology Technology:
(Date:3/27/2017)... CENTRE, N.Y. , March 27, 2017 /PRNewswire-USNewswire/ ... Healthcare Information and Management Systems Society (HIMSS) Analytics ... Outpatient EMR Adoption Model sm . In addition, ... 12% of U.S. hospitals using an electronic medical ... CHS for its high level of EMR usage ...
(Date:3/23/2017)... 23, 2017 Research and Markets has announced ... & Trends - Industry Forecast to 2025" report to their ... The ... CAGR of around 8.8% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
(Date:3/20/2017)... , March 20, 2017 At this year,s ... -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand ... is this year,s CeBIT partner country. At the largest German biometrics ... in use: fingerprint, face and iris recognition as well as DERMALOG´s multi-biometrics ... ...
Breaking Biology News(10 mins):